Capture.JPG

State of CDER 2019: What’s New? 

Janet Woodcock, MD, CDER’s Center Director, delivered the State of CDER 2019 podcast, reflecting the accomplishments of the past year and priorities for 2019

  •  New Drug/Biologic Regulatory Program Modernization
  • Drug Shortages
  • Compounding
  • OTC Monograph User Fee Program
  • Opioid Crisis

LISTEN


Image credit: FDA

Advertisements